Research Projects & Grants

For Profit Organization

  • The clomethizole acute stroke study in acute ischemic stroke (class-I): a double blind, parallel group, multinational, multicenter study of the efficacy and safety of i.v. clomethiazole compared to placebo in patients with acute ischemic stroke. Study code: SA-CMZ-0009 (Protocol dated 08/21/97 and Amendment No. 1 dated 06/23/98)., Role: Investigator, ASTRA (USA), (07/2000 - 07/2001) Status: Completed
  • Titration to response: Analysis of individualized therapy study (TRAITS) Protocol Capss -048, Role: Investigator, Ortho-McNeil Pharmaceutical, (06/1999 - 06/2000) Status: Completed
  • Open-label study to identify the reasons for TASMAR dosage regimen changes in fluctuating Parkinson's disease patients, with follow-up extension, Role: Investigator, Hoffmann-La Roche Inc., (08/1998 - 08/1999) Status: Completed
  • A phase III, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the safety and efficacy of a 24-hr infusion of Cervene in patients with acute ischemic stroke, Role: Investigator, Baker Norton Pharmaceuticals, (06/1997 - 06/1998) Status: Completed
  • A Trial of Recombinant Methionyl Human Brain-Derived Neurotrophic Factor (r-metHuBDNF) Given by Daily Subcutaneous Injection to Patients with Amyotrophic Lateral Sclerosis (ALS), Role: Investigator, Amgen, Inc., (07/1996 - 07/1997) Status: Completed
  • A Randomized, Triple-Blind, Placebo-Controlled, Outpatient Study to Examine the Safety and Efficacy of 10 mg p.o. MK-462 in the Treatment of Multiple Attacks of Migraine Headache, Role: Investigator, Merck, Sharp, and Dohme (MSD) Research Foundation, (04/1996 - 04/1997) Status: Completed
  • A Randomized, Triple Blind, Placebo-Controlled, Outpatient Study to Examine the Safety and Efficacy of 10 mg p.o. MK-0462 in the Treatment of Multiple Attacks of Migraine Headache (Preliminary), Role: Investigator, Merck, Sharp, and Dohme (MSD) Research Foundation, (03/1996 - 03/1997) Status: Completed
  • Clinical experience and use of sabril in patients with partial seizures, Role: Investigator, Marion Merrell Dow, (01/1996 - 01/1997) Status: Completed
  • A Double-Blind, Placebo-Controlled Study Assessing the Efficacy of Gabapentin in Patients with Amyotrophic Lateral Sclerosis (ALS), Role: Investigator, Warner Lambert, (10/1995 - 10/1996) Status: Completed
  • A Trial of Recombinant Methionyl Human Brain-Derived Neurotrophic Factor (r-metHuBDNF)Given by Daily Subcutaneous Injection to Patients with Amyotrophic Lateral Sclerosis (ALS). [Advertising Stage], Role: Investigator, Amgen, Inc., (07/1995 - 07/1996) Status: Completed
  • The BETASERON Patient Experience Study, Role: Investigator, National Medical Research Corp., (06/1995 - 06/1996) Status: Completed

Internal

  • A study of midodrine in patients with neurogenic orthostatic hypotension. Protocol #20.762-999A, Role: Investigator, LLU Dept. of Neurology, (07/1996 - 07/1997) Status: Completed